June 29, 2020 / 12:04 PM / 6 days ago

BRIEF-Aptose Announces FDA Allowance Of IND For Phase 1A/B Study Of Cg-806 In Acute Myeloid Leukemia

June 29 (Reuters) - Aptose Biosciences Inc:

* APTOSE ANNOUNCES FDA ALLOWANCE OF IND FOR PHASE 1A/B STUDY OF CG-806 IN ACUTE MYELOID LEUKEMIA

* APTOSE BIOSCIENCES INC - INTENDS TO INITIATE PHASE 1 A/B STUDY OF CG-806 IN SECOND HALF OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below